C. R. Bard website screenshot

C. R. Bard

C. R. Bard, Inc. was an American multinational developer, manufacturer, and marketer of medical technologies in the fields of vascular, urology, oncology, and surgical specialties. Bard was founded in 1907 by Charles Russell Bard and was acquired by Becton, Dickinson and Company (BD) in December 2017 for approximately $24 billion. Bard's product lines now operate as part of BD's Interventional segment under the BD Bard brand. No public API or developer portal is published; integrations with hospital and provider systems are arranged through BD enterprise channels.

C. R. Bard is profiled on the APIs.io network. Tagged areas include BD, Becton Dickinson, Interventional, Medical Devices, and Medical Technology.

🌐 Visit website 📡 Source on GitHub
11.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
BDBecton DickinsonInterventionalMedical DevicesMedical TechnologyOncologySurgeryUrologyVascularFortune 1000

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.0/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cr-bard: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Cr Bard Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Press 5

Recent news and press coverage referencing this provider.

5 takeaways from Becton Dickinson's $24B acquisition of ...

2026-05-25

C. R. Bard, Inc. to Acquire Medivance for $250 Million

2026-05-25

Boston Scientific Buys C.R. Bard's Electrophysiology ...

2026-05-25

BD Completes Bard Acquisition, Creating New Global ...

2026-05-25

BD accelerates offerings with Bard

2026-05-25

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

ContactBD
ContactBD

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 LegacyWebsite
LegacyWebsite
 BDLinkedIn
BDLinkedIn

Other 3

Properties that don't map to a standard resource type

BDBardBrand
BDBardBrand
 BDInterventional
BDInterventional
 BDAcquisitionAnnouncement
BDAcquisitionAnnouncement

Source (apis.yml)

apis.yml Raw ↑ 
aid: cr-bard
name: C. R. Bard
kind: company
description: C. R. Bard, Inc. was an American multinational developer, manufacturer, and marketer of medical technologies
  in the fields of vascular, urology, oncology, and surgical specialties. Bard was founded in 1907 by Charles Russell Bard
  and was acquired by Becton, Dickinson and Company (BD) in December 2017 for approximately $24 billion. Bard's product lines
  now operate as part of BD's Interventional segment under the BD Bard brand. No public API or developer portal is published;
  integrations with hospital and provider systems are arranged through BD enterprise channels.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/cr-bard.png
url: https://raw.githubusercontent.com/api-evangelist/cr-bard/refs/heads/main/apis.yml
type: Index
access: 3rd-Party
position: Consuming
created: '2024-01-01'
modified: '2026-04-28'
tags:
- BD
- Becton Dickinson
- Interventional
- Medical Devices
- Medical Technology
- Oncology
- Surgery
- Urology
- Vascular
- Fortune 1000
apis: []
common:
- type: DomainSecurity
  url: security/cr-bard-domain-security.yml
- type: Website
  url: https://www.bd.com/en-us
- type: BDBardBrand
  url: https://www.bd.com/en-us/products-and-solutions/products/product-brands/bard
- type: LegacyWebsite
  url: https://www.crbard.com
- type: BDInterventional
  url: https://www.bd.com/en-us/about-bd/our-businesses/bd-interventional
- type: BDAcquisitionAnnouncement
  url: https://news.bd.com/2017-12-29-BD-Completes-Acquisition-of-C-R-Bard
- type: ContactBD
  url: https://www.bd.com/en-us/about-bd/contact-us
- type: BDLinkedIn
  url: https://www.linkedin.com/company/bd1/
- type: PrivacyPolicy
  url: https://www.bd.com/en-us/about-bd/privacy-statement
- type: TermsOfService
  url: https://www.bd.com/en-us/about-bd/terms-of-use
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com